Guru Ownership Trend
Guru Analysis for Eikon Therapeutics, Inc. (EIKN)
Eikon Therapeutics, Inc. (EIKN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $344,407.28.
Top institutional holders include Renaissance Technologies (RenTech) and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $349,701 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Eikon Therapeutics, Inc. (EIKN)
Major holders include Renaissance Technologies (RenTech) ($349,701), Paul Tudor Jones ($195,750). According to the latest reported data, 2 tracked investment managers collectively hold approximately 41,797 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $349,701, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in EIKN during the most recent reporting period.
Yes, 1 managers opened new positions in EIKN, and 0 increased their existing holdings. The total reported buy value was $349,701.